Oxaliplatin and irinotecan chemotherapy in advanced gastric cancer.: Final results of a multicenter phase II trial.

被引:0
|
作者
Woell, E.
Kuehr, T.
Eisterer, W.
Gattringer, K.
Greil, R.
Zabernigg, A.
Hilbe, W.
Thaler, J.
机构
[1] St Vincent Hosp Zams, Zams, Austria
[2] Klinikum Kreuzschwestern, Wels, Austria
[3] Med Univ Innsbruck, Innsbruck, Austria
[4] Kufstein Hosp, Kufstein, Austria
[5] Med Univ Klin, Salzburg, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4070
引用
收藏
页码:195S / 195S
页数:1
相关论文
共 50 条
  • [1] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [2] Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
    Woell, E.
    Kuehr, T.
    Eisterer, W.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Hilbe, W.
    Thaler, J.
    ANTICANCER RESEARCH, 2008, 28 (5B) : 2901 - 2905
  • [3] Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric-2
    Woell, E.
    Greil, R.
    Eisterer, W.
    Fridrik, M.
    Gruenberger, B.
    Gattringer, K.
    Mayrbaeurl, B.
    Russ, G.
    Thaler, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Oxaliplatin, Irinotecan and Cetuximab in Advanced Gastric Cancer. A Multicenter Phase II Trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
    Woell, Ewald
    Greil, Richard
    Eisterer, Wolfgang
    Bechter, Oliver
    Fridrik, Michael A.
    Gruenberger, Birgit
    Zabernigg, August
    Mayrbaeurl, Beate
    Russ, Gudrun
    Dlaska, Margit
    Obrist, Peter
    Thaler, Josef
    ANTICANCER RESEARCH, 2011, 31 (12) : 4439 - 4443
  • [5] Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)
    Woell, E.
    Greil, R.
    Eisterer, W.
    Fridrik, M.
    Gruenberger, B.
    Zabernigg, A.
    Mayrbaeurl, B.
    Russ, G.
    Thaler, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Pemetrexed plus oxaliplatin in the management of advanced gastric cancer:: A multicenter phase II trial
    Bajetta, Emilio
    Celio, Luigi
    Calabro, Fabio
    Mosconi, Stefania
    La Torre, Ignazia
    Barone, Carlo
    Berardi, Rossana
    Amoroso, Vito
    Pinotti, Graziella
    Di Costanzo, Francesco
    ANNALS OF ONCOLOGY, 2006, 17 : 313 - 313
  • [7] Final results of a phase II multicenter study of neoadjuvant S-1 and irinotecan in patients with locally advanced gastric cancer
    Terashima, Masanori
    Saze, Zenichiro
    Hosotani, Ryo
    Takahashi, Masahiro
    Takagane, Akinori
    Hachiya, Osamu
    Koeda, Keisuke
    Matsui, Shigeyuki
    Fukushima, Norimasa
    Kawasaki, Hitoshi
    Gotoh, Mitsukazu
    Fukushima, Masanori
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [8] Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
    Pasquale Comella
    Vito Lorusso
    Luigi Maiorino
    Rossana Casaretti
    Michele Cannone
    Bruno Massidda
    Carlo Putzu
    Silvana Leo
    Mario Roselli
    Sergio Mancarella
    Sergio Palmeri
    Ettore Greco
    Giacomo Vessia
    Claudia Sandomenico
    Luca Franco
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 893 - 899
  • [9] Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
    Comella, Pasquale
    Lorusso, Vito
    Maiorino, Luigi
    Casaretti, Rossana
    Cannone, Michele
    Massidda, Bruno
    Putzu, Carlo
    Leo, Silvana
    Roselli, Mario
    Mancarella, Sergio
    Palmeri, Sergio
    Greco, Ettore
    Vessia, Giacomo
    Sandomenico, Claudia
    Franco, Luca
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (05) : 893 - 899
  • [10] Triple induction chemotherapy and chemoradiotherapy in locally advanced esophageal cancer: Final results of a multicenter phase II trial
    Eisterer, W. M.
    De Vries, A.
    Spechtenhauser, B.
    Kendler, D.
    Koenigsrainer, A.
    Nehoda, H.
    Lukas, P.
    Woell, E.
    Oefner, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)